Ganetespib: research and clinical development

nork Jhaveri, Komal, Modi, Shanu
Argitaratua izan da Onco Targets Ther (2015)

HER2 breast cancer therapies: a review

nork Murphy, Conleth G, Modi, Shanu
Argitaratua 2009

Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current stat...

nork Spring, Laura, Bardia, Aditya, Modi, Shanu
Argitaratua izan da Discov Med (2016)

Unlocking the potential of antibody–drug conjugates for cancer therapy

nork Drago, Joshua Z., Modi, Shanu, Chandarlapaty, Sarat
Argitaratua izan da Nat Rev Clin Oncol (2021)

Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

nork Jhaveri, Komal, Taldone, Tony, Modi, Shanu, Chiosis, Gabriela
Argitaratua 2011

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

nork Patel, Hardik J, Modi, Shanu, Chiosis, Gabriela, Taldone, Tony
Argitaratua 2011

Chaperome heterogeneity and its implications for cancer study and treatment

nork Wang, Tai, Rodina, Anna, Dunphy, Mark P., Corben, Adriana, Modi, Shanu, Guzman, Monica L., Gewirth, Daniel T., Chiosis, Gabriela
Argitaratua izan da J Biol Chem (2019)

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

nork Corben, Adriana D., Uddin, Mohammad M., Crawford, Brooke, Farooq, Mohammad, Modi, Shanu, Gerecitano, John, Chiosis, Gabriela, Alpaugh, Mary L.
Argitaratua izan da J Vis Exp (2014)

Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer

nork Freites-Martinez, Azael, Shapiro, Jerry, Chan, Donald, Fornier, Monica, Modi, Shanu, Gajria, Devika, Dusza, Stephen, Goldfarb, Shari, Lacouture, Mario E.
Argitaratua izan da JAMA Dermatol (2018)

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

nork Krop, Ian E., Modi, Shanu, LoRusso, Patricia M., Pegram, Mark, Guardino, Ellie, Althaus, Betsy, Lu, Dan, Strasak, Alexander, Elias, Anthony
Argitaratua izan da Breast Cancer Res (2016)

The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation

nork Yang, T. Jonathan, Morrow, Monica, Modi, Shanu, Zhang, Zhigang, Krause, Kate, Siu, Chun, McCormick, Beryl, Powell, Simon N., Ho, Alice Y.
Argitaratua izan da Ann Surg Oncol (2015)

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

nork Modi, Shanu, Saura, Cristina, Henderson, Charles, Lin, Nancy U., Mahtani, Reshma, Goddard, Jill, Rodenas, Eduardo, Hudis, Clifford, O’Shaughnessy, Joyce, Baselga, Jose
Argitaratua 2013

Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up

nork Wang, Rui, Smyth, Lillian M., Iyengar, Neil, Chandarlapaty, Sarat, Modi, Shanu, Jochelson, Maxine, Patil, Sujata, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Argitaratua izan da Oncologist (2019)

Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer

nork Chandarlapaty, Sarat, Sakr, Rita A., Giri, Dilip, Patil, Sujata, Heguy, Adriana, Morrow, Monica, Modi, Shanu, Norton, Larry, Rosen, Neal, Hudis, Clifford, King, Tari A.
Argitaratua 2012

Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging and lung metastases in patients with breast cancer

nork Morris, Patrick G., Zhou, Xi Kathy, Milne, Ginger L., Goldstein, Daniel, Hawks, Laura C., Dang, Chau T., Modi, Shanu, Fornier, Monica N., Hudis, Clifford A., Dannenberg, Andrew J.
Argitaratua 2013

A Phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer

nork Jhaveri, Komal, Drago, Joshua Z., Shah, Payal Deepak, Wang, Rui, Pareja, Fresia, Ratzon, Fanni, Iasonos, Alexia, Patil, Sujata, Rosen, Neal, Fornier, Monica N., Sklarin, Nancy T., Chandarlapaty, Sarat, Modi, Shanu
Argitaratua izan da Clin Cancer Res (2021)

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

nork Freites-Martinez, Azael, Chan, Donald, Sibaud, Vincent, Shapiro, Jerry, Fabbrocini, Gabriella, Tosti, Antonella, Cho, Juhee, Goldfarb, Shari, Modi, Shanu, Gajria, Devika, Norton, Larry, Paus, Ralf, Cigler, Tessa, Lacouture, Mario E.
Argitaratua izan da JAMA Dermatol (2019)

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

nork Jhaveri, Komal, Ochiana, Stefan O, Dunphy, Mark PS, Gerecitano, John F, Corben, Adriana D, Peter, Radu I, Janjigian, Yelena Y, Gomes-DaGama, Erica M, Koren, John, Modi, Shanu, Chiosis, Gabriela
Argitaratua 2014

Biomarkers that Predict Sensitivity to Heat Shock Protein 90 Inhibitors (HSP90i)

nork Jhaveri, Komal, Chandarlapaty, Sarat, Iyengar, Neil, Morris, Patrick G., Corben, Adriana D, Patil, Sujata, Akram, Muzaffar, Towers, Russell, Sakr, Rita A, King, Tari A, Norton, Larry, Rosen, Neal, Hudis, Clifford, Modi, Shanu
Argitaratua izan da Clin Breast Cancer (2015)

Pilot study of (68)Ga-DOTA-F(ab′)(2)-trastuzumab in patients with breast cancer

nork Beylergil, Volkan, Morris, Patrick G., Smith-Jones, Peter M., Modi, Shanu, Solit, David, Hudis, Clifford A., Lu, Yang, O’Donoghue, Joseph, Lyashchenko, Serge K., Carrasquillo, Jorge A., Larson, Steven M., Akhurst, Timothy J.
Argitaratua 2013